This supplement features FDA updates, clinical trials, and the latest research in myeloid malignancies.
This issue features a look at the U.S. health-care system’s transition from a paper-based system to electronic health records, an introduction to a series about oncology nurse practitioners, and more.
This supplement features a look at controversies in myeloma treatment, the future of immunotherapy for lymphoma, newly approved and investigational therapies, and more.
This issue features a debate over whether CPX-351 can be used with other therapies in AML, a look at contract research organizations, and more.
This issue features a conversation with National Cancer Institute Director Norman “Ned” Sharpless, MD, a look at the prevalence and controversial nature of academic-industry partnerships, and more.
This issue features highlights from the 2017 ASH Annual Meeting, including a look at the first anti-sickling agent for sickle cell disease, and more.
This issue features a look at the misconceptions that challenge the viability of the blood-banking system, highlights from the 2017 ASH Annual Meeting, and more.
This issue features physicians' insights on gun control, the use of cannabis for symptom relief, and more.
This issue features a behind-the-scenes look at the ASH annual meeting, bringing newly approved gene therapies to patients, and more.
This issue features a look at hospital ranking systems, the risks and benefits of opioids for pain management, and more.